Report overview
Digital PCR (Digital PCR-dPCR) technology is a new method for nucleic acid detection and quantification. Unlike traditional quantitative PCR (qPCR) technology, digital PCR uses absolute quantification and does not rely on standard curves and reference samples to directly detect targets The copy number of the sequence. Because this detection method has better sensitivity, specificity and accuracy than traditional qPCR, dPCR has been widely used quickly. This technology is used in the detection of very small amounts of nucleic acid samples, detection of rare mutations in complex backgrounds and identification of small differences in expression levels. The realized advantages have been widely recognized, and its many advantages in gene expression research, microRNA research, genome copy number identification, rare mutation detection of cancer markers, identification of pathogenic microorganisms, identification of transgenic components, accurate quantification of NGS sequencing libraries, and result verification, etc. The broad application prospects it has already received more and more attention.
This report aims to provide a comprehensive presentation of the global market for Digital PCR, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital PCR. This report contains market size and forecasts of Digital PCR in global, including the following market information:
Global Digital PCR Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Digital PCR market was valued at US$ 3152 million in 2022 and is projected to reach US$ 3743.7 million by 2029, at a CAGR of 2.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
During the forecast period, the Asia-Pacific region (including China, India, Japan and other regions in the Asia-Pacific region) will develop at a faster growth rate. As global life sciences companies have increased their focus on this region, and this booming development has increased awareness about the diagnosis and treatment of genetic-based diseases, more and more public and private funds are supporting the development of new dPCR technology, Indian Genome. The academic market is rising, and factors such as the continued strengthening of Japanese cancer research have contributed to the rapid development of the Asia-Pacific market. Due to the significant growth opportunities offered by emerging countries, some related companies have begun to focus on expanding their product distribution networks in these emerging markets.
We surveyed the Digital PCR companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Digital PCR Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Digital PCR Market Segment Percentages, by Type, 2022 (%)
Microreactor/Orifice Plate Digital PCR
Microfluidic Chip Digital PCR
Droplet Digital PCR
Global Digital PCR Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Digital PCR Market Segment Percentages, by Application, 2022 (%)
Early Study of Tumor
Quantitative Analysis of A New Generation Sequencing Library
Gene Expression Analysis
Pathogen Detection
Prenatal Diagnosis
Other
Global Digital PCR Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Digital PCR Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Digital PCR revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Digital PCR revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
F. Hoffman-LA Roche Ltd.
Qiagen N.V.
Agilent Technologies, Inc.
Takara Bio, Inc.
Biom?rieux S.A.
Affymetrix, Inc.
Fluidigm Corporation
Raindance Technologies, Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Digital PCR, market overview.
Chapter 2: Global Digital PCR market size in revenue.
Chapter 3: Detailed analysis of Digital PCR company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Digital PCR in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
